535 related articles for article (PubMed ID: 10076998)
21. Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation.
Hansen LH; Madsen B; Teisner B; Nielsen JH; Billestrup N
Mol Endocrinol; 1998 Aug; 12(8):1140-9. PubMed ID: 9717840
[TBL] [Abstract][Full Text] [Related]
22. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
Mu YM; Yanase T; Nishi Y; Waseda N; Oda T; Tanaka A; Takayanagi R; Nawata H
Biochem Biophys Res Commun; 2000 May; 271(3):710-3. PubMed ID: 10814527
[TBL] [Abstract][Full Text] [Related]
23. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
[TBL] [Abstract][Full Text] [Related]
24. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
25. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
26. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
27. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
28. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders.
Nuttall ME; Patton AJ; Olivera DL; Nadeau DP; Gowen M
J Bone Miner Res; 1998 Mar; 13(3):371-82. PubMed ID: 9525337
[TBL] [Abstract][Full Text] [Related]
29. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
Ibrahimi A; Teboul L; Gaillard D; Amri EZ; Ailhaud G; Young P; Cawthorne MA; Grimaldi PA
Mol Pharmacol; 1994 Dec; 46(6):1070-6. PubMed ID: 7808426
[TBL] [Abstract][Full Text] [Related]
31. p120 acts as a specific coactivator for 9-cis-retinoic acid receptor (RXR) on peroxisome proliferator-activated receptor-gamma/RXR heterodimers.
Monden T; Kishi M; Hosoya T; Satoh T; Wondisford FE; Hollenberg AN; Yamada M; Mori M
Mol Endocrinol; 1999 Oct; 13(10):1695-703. PubMed ID: 10517671
[TBL] [Abstract][Full Text] [Related]
32. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
Adams M; Montague CT; Prins JB; Holder JC; Smith SA; Sanders L; Digby JE; Sewter CP; Lazar MA; Chatterjee VK; O'Rahilly S
J Clin Invest; 1997 Dec; 100(12):3149-53. PubMed ID: 9399962
[TBL] [Abstract][Full Text] [Related]
33. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
34. PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes.
Teruel T; Clapham JC; Smith SA
Biochem Biophys Res Commun; 1999 Oct; 264(2):311-5. PubMed ID: 10529360
[TBL] [Abstract][Full Text] [Related]
35. Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.
Rieusset J; Auwerx J; Vidal H
Biochem Biophys Res Commun; 1999 Nov; 265(1):265-71. PubMed ID: 10548525
[TBL] [Abstract][Full Text] [Related]
36. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi P; Xu M; Spiegelman BM
J Clin Invest; 1997 Oct; 100(7):1863-9. PubMed ID: 9312188
[TBL] [Abstract][Full Text] [Related]
37. PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes.
Camp HS; Whitton AL; Tafuri SR
FEBS Lett; 1999 Mar; 447(2-3):186-90. PubMed ID: 10214942
[TBL] [Abstract][Full Text] [Related]
38. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
39. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone induces expression of PPARgamma in liver.
Davies GF; Khandelwal RL; Roesler WJ
Mol Cell Biol Res Commun; 1999; 2(3):202-8. PubMed ID: 10662598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]